Panel Recommends Japan Continue Ban On Tamiflu For Teenagers
This article was originally published in PharmAsia News
Executive SummaryJapan is keeping in place for now its ban on the use of Roche's Tamiflu (oseltamivir) flu drug for teenagers. A panel convened by the Health, Labor and Welfare Ministry recommended the ban be kept in place after reviewing a survey on the risk of abnormal behavior by teens who took the drug. Researchers are calling for more studies to determine the exact cause of the abnormal behavior, some saying it could have been the flu itself and not the drug to treat it that was responsible. The ban on its use in teens took effect just over two years ago, but it also is one of the major treatments for the H1N1 flu now affecting many Japanese. (Click here for more
You may also be interested in...
San Francisco-based digital health start-up Steady Health has launched the first "virtual" full-service diabetes clinic for patients in California. See what Henrik Berggren, CEO and founder of Steady Health, said about it here.
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.